Anti-neutrophil cytoplasmic antibodies in a rat model of trinitrobenzenesulphonic acid-induced liver injury

European Journal of Clinical Investigation

Volumn 29, Issue 11, 1999, Pages 929-939

  Orth, T ^a   Neurath, M ^a   Schirmacher, P ^b   Treichel, U ^a   Meyer Zum Buschenfelde K H ^a   Mayet, W J ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Department of Internal Medicine ^*

Author keywords

Anti neutrophil cytoplasmic antibodies; Antigen; Autoantibody; Catalase; Liver; Rat

Indexed keywords

ACTIN; ASIALOGLYCOPROTEIN RECEPTOR; AUTOANTIBODY; CATALASE; IMMUNOGLOBULIN G ANTIBODY; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BILE DUCT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; LIVER INJURY; LIVER NECROSIS; LIVER PARENCHYMA; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN LYMPHOCYTE; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LIVER; MACROPHAGES; NECROSIS; RATS; RATS, INBRED LEW; T-LYMPHOCYTES; TRINITROBENZENESULFONIC ACID;

EID: 0032760253     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00547.x     Document Type: Article

References (33)

1. 1 Goldschmeding R, van der Schoot CE, ten Bokkel Huinink D, Hack CE, van den Ende ME, Kallenberg GCM, et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest, 1989;84:1577-87.
2. 2 Niles JL, McCluskey RT, Ahmad MF, Arnaout MA. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood, 1989;74:1888-93.
3. 3 Lüdemann J, Utrecht B, Gross WL. Anti-neutrophil cytoplasmic antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med, 1990;171:357-62.
4. 4 Falk RJ, Jenette JC. Anti-neutrophil cytoplasmic antibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med, 1988;318:1651-7.
5. 5 Krawitt EL. Autoimmune hepatitis. N Engl J Med, 1996;334:897-903.
6. 6 Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology, 1995;108:1159-66.
7. 7 Orth T, Gerken G, Kellner R, Meyer zum Büschenfelde KH, Mayet WJ. Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1. J Hepatol, 1997;26:37-47.
8. 8 Wiessner RH. Current concepts in primary sclerosing cholangitis. Mayo Clin Proc, 1994;69:969-82.
9. 9 Peen E, Almer S, Bodemar G, Ryden BO, Sjölin C, Tejle, et al. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut, 1993;34:56-62.
10. 10 Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CGM. Prevalence and characterization of neutrophil cytoplasmic autoantibodies in autoimmune liver disease. Hepatology, 1993;17:411-7.
11. 11 Ellerbrock PM, Oudkerk Pool M, Ridwan BU, Dolman KM, von Blomberg BME, Kr von dem Borne AEG, et al. Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol, 1994;47:257-62.
12. 12 Mulder AHL, Broekroelofs J, Horst G, Limburg PC, Nelis GF, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clin Exp Immunol, 1994;95:490-7.
13. 13 Orth T, Gerken G, Meyer zum Büschenfelde KH, Mayet WJ. Antineutrophil nuclear antibodies (ANNA) in patients with primary biliary cirrhosis: their prevalence and antigen specificity. Z Gastroenterol, 1997;35:113-21.
14. 14 Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology, 1989;96:795-803.
15. 15 Treichel U, Schreiter T, Meyer zum Büschenfelde KH, Stocken RJ. High-Yield Purification and Characterization of Human Asialoglycoprortein Receptor. Prat Exp Purif, 1995;6:251-5.
16. 16 Böhm J, Orth T, Nguyen Van P, Söling H-D. Systemic lupus erythematosus is associated with increased autoantibody titres against calreticulin and Grp94, but calreticulin is not the Ro/SS-A antigen. Eur J Clin Invest, 1994;24:248-57.
17. 17 Laemmli UK. Cleavage of structural proteins during the assembly of the bacteriophage T4. Nature, 1970;227:680-5.
18. 18 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA, 1979;76:4350-4.
19. 19 Little JR, Eisen HN. Preparation and charcterization of antibodies specific for the 2,4,6-trinitrophenyl group. Biochemistry, 1966;5: 3385-95.
20. 20 Neurath MF, Fuss I, Kelsall BL, Stüber W, Strober W. Antibodies to IL-12 abrogate established experimental colitis in mice. J Exp Med, 1995;182:1281-90.
21. + T cells. J Immunol, 1995;154:1232-8.
22. 22 Orth T, Kellner R, Diekmann O, Faust J, Meyer zum Büschenfelde KH, Mayet WJ. Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol, 1998;112:507-15.
23. 23 Roozendaal C, Zhao MH, Horst G, Lockwood CM, Kleibeuker JH, Limburg PC, et al. Catalase and α-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD). Clin Exp Immunol, 1998;112:10-6.
24. 24 Ballinger CA, Mendis-Handagama SMLC, Kalmar JK, Arnold RR, Kinkade JM. Changes in the localization of catalase during differentiation of neutrophilic granulocytes. Blood, 1994;83:2654-68.
25. 25 Michiels C, Raes M, Toussaint O, Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radical Biol Med, 1994;17:235-48.
26. 26 Kasahara Y, Iwai K, Yachie A, Ohta K, Konno A, Eki H, et al. Involvement of reactive oxygen intermediates in spontaneous and, CD95 (FAS/APO-1) mediated apoptosis of neutrophils. Blood, 1997;89:1748-53.
27. 27 Nagayama S, Kitamura R, Yokoi T, Kawaguchi W, Kasai N, Takeichi N, et al. Occurrence of autoimmune autoantibodies to liver microsomal proteins in association with fulminant hepatitis in the LEG strain of rats. Biochem Biophys Res Commun, 1991;179:1134-40.
28. 28 Saracco G, Touscoz A, Durazzo M, Rosina F, Dnegani E, Chiandussi L, et al. Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis. J Hepatol, 1990;11:339-43.
29. 29 Mayet WJ, Hess G, Gerken G, Rossol S, Voth R, Manns M, et al. Treatment of chronic type B hepatitis with recombinant alpha interferon induces autoantibodies not specific for autoimmune hepatitis. Hepatology, 1989;10:24-8.
30. 30 Beaune P, Dansette PM, Mansey D, Kiffel L, Frick M, Amar M, et al. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci USA, 1987;84:551-5.
31. 31 Esnault VLM, Mathieson PW, Thiru S, Oliveira DBG, Lockwood CM. Autoantibodies to Myeloperoxidase in Brown Norway Rats Treated with Mercuric Chloride. Lab Invest, 1992;67:114-20.
32. 32 Mathieson PW, Thiru S, Oliveira DBG. Mercuric chloride-treated brown Norway rats develop widespread tissue injury including necrotizing vaculitis. Lab Invest, 1992;67:121-9.
33. 33 Brouwer E, Huitema MG, Klok PA, de Weerd H, Cohen Tervaert JW, Weening JJ, et al. Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med, 1993;177:905-14.